•
Mar 31, 2021
CryoPort Q1 2021 Earnings Report
Cryoport's revenue grew to a record $53.3 million, driven by the Biopharma/Pharma market and recent acquisitions.
Key Takeaways
Cryoport reported a strong first quarter with record revenue of $53.3 million, driven by growth in all operating units and contributions from recent acquisitions. The Biopharma/Pharma market represented approximately 80% of total revenue. The company supported a record 543 regenerative medicine clinical trials.
Cryoport's revenue grew to a record $53.3 million.
All business units reported record revenue and strong sequential growth.
The Biopharma/Pharma market represented approximately 80% of total revenue.
Cryoport supported a record 543 regenerative medicine clinical trials.